Association between Vitamin D Supplements... (2021 study) Skip to main content
Clinical Study Oxidative medicine and cellular longevity 2021

Association between Vitamin D Supplements, Oxidative Stress Biomarkers, and Hyperbaric Therapy in Patients with Sudden Sensorineural Hearing Loss.

Paprocki J, Sutkowy P, Piechocki J, Woźniak A, Oxidative medicine and cellular longevity, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers measured blood markers of oxidative stress in patients with sudden sensorineural hearing loss who were treated with hyperbaric oxygen (HBO) therapy, and compared those who did and did not also take vitamin D (cholecalciferol, 4000 IU per day).

What They Found

This study of patients with sudden sensorineural hearing loss given HBO therapy found no statistically significant differences in oxidative stress markers between patients who did and did not receive vitamin D. Blood was collected before the first HBO procedure, within 5 minutes after it, and after 14 procedures. In patients without vitamin D, erythrocyte TBARS rose 53.2% after the first HBO treatment (p less than or equal to 0.05), and haemoglobin fell 10.9% after 14 treatments compared with baseline (p less than or equal to 0.05). In patients receiving vitamin D, erythrocyte MDA fell 27.6% after 14 treatments compared with after the first (p less than or equal to 0.05). Plasma conjugated dienes fell 33.3% after 14 treatments in both groups. Erythrocyte SOD, GPx and CAT activities and haematocrit did not change significantly.

What This Means for Canadian Patients

The study measured blood markers, not hearing recovery, so it does not show whether HBO therapy or vitamin D improves hearing. The authors describe the effect of HBO therapy on oxidative stress markers as inconclusive and complex. They say repeated HBO treatments can cause adaptive changes, and that it is possible vitamin D inhibits lipid peroxidation in red blood cells. Patients with this condition should discuss any vitamin D use with their own physician.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract reports no difference between the vitamin D and non-vitamin D groups, so the vitamin D findings come from changes within groups, and the abstract does not give group sizes or report hearing outcomes.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 33777323
Year Published 2021
Journal Oxidative medicine and cellular longevity
MeSH Terms Adult; Biomarkers; Female; Hearing Loss, Sensorineural; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Oxidative Stress; Vitamin D

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology